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Structured abstract 
Aim: To examine the effects of obesity phenotype on abdominal fat responses to 
regular aerobic exercise. 
Method: Fifty-seven obese men aged 34 to 70 years were divided into two groups 
based on baseline intra-abdominal fat (IF) area measured by computerized 5 
tomography: moderate (< 200 cm2) IF (MIF; n = 33, age: 52.9 ± 10.6 [SD] yr, body 
mass index [BMI]: 29.2 ± 3.1 kg/m2) or high (≥ 200 cm2) IF (HIF; n = 24, age: 53.5 ± 
9.5 yr, BMI: 30.3 ± 3.1 kg/m2). The 12-week exercise program consisted primarily of 
aerobic exercise and met 3 days per week for 90 minutes per session. Weight, BMI, 
body composition (by dual-energy X-ray absorptiometry), IF and subcutaneous fat 10 
(SF) areas were measured before and after the program. 
Results: Regular aerobic exercise reduced weight by 2.3 ± 2.2 kg in MIF and 3.2 ± 3.0 
kg in HIF. HIF reduced significantly more IF area than MIF (15.1 ± 26.0 cm2 in MIF 
and 43.3 ± 41.9 cm2 in HIF), and the difference remained significant after adjusting for 
baseline fat mass, weight change and total energy intake during the 12-week aerobic 15 
exercise. 
Conclusion: Exercise-induced IF reduction may be remarkably influenced by obesity 
phenotype. 
 
Keywords: Intra-abdominal fat, regular exercise, obesity phenotype 20 
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1. Introduction 
It is well accepted that obesity is associated with a number of chronic diseases [1] 
such as hypertension, dyslipidemia and type-2 diabetes, and could be an important 
predictor for incident cardiovascular disease (CVD) and associated premature deaths 
[2]. The prevalence of obesity has been increasing worldwide including in Asian 25 
countries such as Japan [3]. In Japan, despite the fact that only 2–3% has been 
characterized as obese [3], defined by the World Health Organization as a body mass 
index (BMI) ≥ 30 kg/m2, the prevalence of metabolic disorders are relatively high [4, 
5]. This suggests that Japanese individuals are likely to develop CVD or other fatal 
events at even mild levels of obesity. A possible mechanism underlying these 30 
relationships could be obesity phenotype as the Japanese population has been found to 
have greater intra-abdominal fat (IF) area than Caucasians of the same age, BMI, and 
waist [6]. It is well established that excess IF is strongly associated with CVD risk 
factors (e.g., hypertension [7] and type-2 diabetes [8, 9]). In 291 men (ages, 56.4 ± 
12.0 years), Kuk et al. [10] established a threshold of 200 cm2 above which risk of 35 
all-cause mortality was found to be increased. 
Because obesity and IF accumulations are primarily induced by physical inactivity 
and excess energy intake, increased physical activity and dietary modification could be 
an effective way to reduce metabolic disorders [11, 12]. Regular exercise may be more 
effective at decreasing IF than dietary modification; regular exercise was found to 40 
decrease IF area without substantial weight change and preferentially reduce IF area 
compared with subcutaneous fat (SF) [13]. 
Although numerous investigations were conducted to determine the effects of 
regular aerobic exercise on IF levels [14], the results of these exercise studies vary 
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considerably depending on characteristics of the participants at baseline [15]. It has 45 
been suggested that potential influencing factors include physiological, environmental 
and genetic attributes. Obesity phenotype is a possible factor influencing IF responses 
to regular aerobic exercise because of increased fat availability during a single bout of 
prolonged aerobic exercise in IF type obesity [16]. One study examined whether 
obesity phenotype would affect the IF response to a weight-loss intervention in 50 
Japanese women [17]; however, there have been no studies investigating its effects on 
IF response to regular aerobic exercise alone. 
The purpose of this investigation was to determine the effects of obesity 
phenotype on IF responses to regular exercise. We hypothesized that participants with 
high levels of IF would reduce IF to a greater extent than those with moderate levels of 55 
IF. Clearing this mechanism will help establish better exercise programs to prevent 
incident CVD and premature death in the clinical setting. 
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2. Methods 
Participants 
Participants aged 30 to 70 years were recruited through advertisements in local 60 
newspapers. Inclusion criteria were as follows: 1) without a history of CVD such as 
myocardial infarction and stroke, and 2) BMI of greater than 25 kg/m2, according to 
the guidelines set by the Japanese Society for the Study of Obesity [18]. In total, 68 
obese men who met the both criteria participated in this study. 
Based on the computerized tomographic analysis, the participants were divided 65 
into two groups according to Kuk et al. [10]: moderate intra-abdominal fat (MIF) 
obesity (IF area < 200 cm2; n = 40) or high intra-abdominal fat (HIF) obesity (IF area ≥ 
200 cm2; n = 28). Seven participants with MIF obesity and four with HIF obesity were 
unable to successfully complete the study. Hence, 33 men in the MIF obesity group, 
and 24 men in the IF obesity group completed the study requirements. Their baseline 70 
characteristics including prevalence of basal disease (i.e., hypertension, dyslipidemia 
or diabetes mellitus) and drug treatment, alcohol and smoking habit were included in 
Table 1. 
Hypertension was defined as systolic blood pressure (BP) ≥ 140 mmHg, and/or 
diastolic BP ≥ 90 mmHg, and/or receiving current medication for this condition [19]. 75 
Dyslipidemia was defined as the presence of any one of the following four risks: 1) 
total cholesterol ≥ 220 mg/dl, 2) low-density lipoprotein (LDL) cholesterol ≥ 140 
mg/dl, 3) high-density lipoprotein (HDL) cholesterol < 40 mg/dl, 4) triglycerides ≥ 150 
mg/dl, and/or receiving current medication for these conditions [20]. Fasting blood 
glucose (FBG) ≥ 126 mg/dl and/or receiving current medication for this condition was 80 
the criterion for diabetes mellitus [21]. An interview was conducted to ascertain the 
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uses of antihypertensive and lipid medication, treatment for diabetes mellitus, alcohol 
(never, past-, or current drinker) habit, smoking (never, past-, or current smoker) habit, 
fasting status (≥ 8 h), and any histories of CVD. 
The purpose and design of the study were fully explained to each participant 85 
before they gave written informed consent. The research protocol was approved by the 
institutional review board at the University of Tsukuba. 
 
Exercise regimen 
All participants were involved in a 90-min combined exercise program consisting 90 
of aerobic exercise and light resistance training 3 days/week for 12 weeks. Each 
90-minute exercise program began with 15–20 minutes of warm-up activities such as 
stretching and calisthenics. The exercise program was followed by 45–60 minutes of 
brisk walking, mild jogging and/or aerobic dancing, and finished with 15–25 minutes 
of recreational and cool-down activities. All exercise programs were performed under 95 
the supervision of several trained physical trainers at the research center at the 
University of Tsukuba. Participants were instructed to perform aerobic exercise at a 
level that raised their heart rates at or near the heart-rate level corresponding to their 
anaerobic threshold. Additionally, participants were recommended to perform other 
kinds of exercise such as walking, aerobic dancing, and stationary cycling at or around 100 
their homes on days with no exercise program. Each participant recorded his mode and 
duration of this additional exercise on a printed form. To study the effects of exercise 
alone and eliminate the confounding effects of diet-induced weight loss, participants 
were counseled not to change their dietary habit throughout the study period. 
 105 
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Anthropometry and body composition measurements 
Height was measured to the nearest 0.1 cm using a wall-mounted stadiometer 
(YG-200; Yagami, Nagoya, Japan). Weight, percentage of fat mass (%fat), whole-body 
fat mass (FM), and fat-free mass (FFM) were measured by dual-energy X-ray 
absorptiometry using a Lunar DPX-NT densitometer (Lunar, Madison, WI, USA). Pre- 110 
and post-intervention measurements were conducted by the same examiner to minimize 
technical error. BMI was calculated as weight in kilograms divided by squared height 
in meters. 
 
Measurement of maximal oxygen uptake 115 
Maximal oxygen uptake (V
．
O2max) for each participant was determined by a 
graded exercise test with a cycling ergometer (828E, Monark, Stockholm, Sweden). 
Following a 2-min warm up at 30 watts (W), the workload was increased every minute 
by 15 W until volitional exhaustion. During the test, ventilations and expiratory gases 
were measured using an indirect calorimeter (Oxycon Alpha, Mijnhardt, Breda, 120 
Netherlands). The highest oxygen uptake achieved over 30 seconds was determined as 
V
．
O2max. The V
．
O2max was analyzed in the method described by Tanaka et al. [22]. 
Anaerobic threshold (AT) was determined as a nonlinear increase in V
．
E when plotted 
against V
．
O2 or a simultaneous breakpoint in V
．
E/V
．
O2 and the partial pressure of oxygen 
in end-tidal expired air [23]. 125 
 
Abdominal fat area by computerized tomography 
The IF, SF and total fat (TF) areas (centimeters squared) were measured at the 
umbilicus level using computerized tomography (CT) scans (Somatom AR.C; Siemens, 
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Erlangen, Germany) performed on participants in the supine position with their arms 130 
stretched above their head. Each participant was clothed only in a loose-fitting gown 
since restrictive clothing had been determined to alter the detection of fat distribution. 
Pre- and post-intervention measurements were conducted by the same technician. The 
IF and SF areas were calculated using a computer software program (FatScan; 
N2system, Osaka, Japan) according to the method of Yoshizumi et al. [24]. We directly 135 
estimated visceral adiposity from the IF area. This measurement has been reported to 
have a high correlation with directly ascertained total visceral fat volume [25]. The 
intra-class correlation for repeated IF area determinations in our laboratory was 0.98 (n 
= 37). 
 140 
Measurement of cardiovascular risk factors 
Systolic and diastolic BP were measured by trained observers using a standard 
mercury sphygmomanometer (cuff size 14 × 47 cm) on the right arm of seated 
participants who had rested for at least 10 minutes. A blood sample was drawn from 
each participant after an overnight (≥ 8 h) fast. Plasma concentrations of free fatty acid 145 
(FFA) were analyzed by colorimetric method. Serum total cholesterol and triglycerides 
were determined enzymatically, serum HDL cholesterol was measured by the 
heparin-manganese precipitation method. Serum LDL cholesterol was estimated 
according to the equation of Friedewald et al. [26]. FBG was assayed by a glucose 
oxidase method. 150 
 
Energy intake assessments 
Total energy intake (TEI) in kilocalories and macronutrient (carbohydrates, 
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protein, and fat) balances before and during a 2-week period (weeks 9 and 10) of the 
exercise program were assessed by 3-day weighed dietary records (3-day WDR) and 155 
dietary recall interviews for each participant performed by skilled dieticians. We 
explained how to complete the 3-day WDR in detail before taking measurements. The 
participants learned to use a digital cooking scale for weighing food. The dietitians 
collected the recorded sheets from the 3-day WDR and codified the food items and 
food weights. Thereafter, the dieticians interviewed each participant to elicit more 160 
information about their food intake for the 3-day period. Based on the Standard Tables 
of Food Composition in Japan fourth revised edition [27], TEI along with carbohydrate, 
fat, and protein intakes were calculated. 
 
Energy expenditure assessments 165 
The total energy expenditure (TEE) and physical activity energy expenditure 
(PAEE) were assessed by a uniaxial accelerometer (Lifecorder; Suzuken Co. Ltd., 
Nagoya, Japan). Measurements of TEE using the accelerometer were validated against 
doubly-labeled water method [28] and metabolic chamber method [29], both of which 
were considered as free-living and laboratory based gold standards for TEE 170 
measurements, respectively. The accelerometer can assess two types of activity-related 
energy expenditure: energy expenditure of activities (EEAct) indicating ≥ 1.8 metabolic 
equivalents (METs) and energy expenditure of minor activities (EEminorAct) indicating 
<1.8 METs [30]. In this study, the former was considered as PAEE. The TEE was 
calculated from the sum of the basal metabolic rate (BMR), diet-induced 175 
thermogenesis (10%TEE), EEAct and EEminorAct. The BMR was estimated from sex, age, 
weight and height using a standard Japanese formula [31]. Detailed descriptions of the 
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accelerometer have been published elsewhere [29]. Participants wore the 
accelerometer regularly (except while sleeping or bathing), for a 2-week period prior 
to the 12-week intervention and during a 2-week period during the intervention (weeks 180 
9 and 10). To eliminate reporting bias, no correction was used for those activities 
(swimming, weight lifting, cycling, etc), which can not be captured by the 
accelerometers. 
 
Statistical analysis 185 
All results were shown as mean ± standard deviation. To compare change in each 
item between groups, a two-way repeated measures analysis of variance (time × group) 
was applied. An unpaired Student’s t test or a chi-squared test was used to compare 
variables between the groups at baseline. A paired Student’s t test was used to 
determine the significance of differences between pre- and post-intervention data. An 190 
analysis of covariance (ANCOVA) was used, with absolute changes acting as 
dependent variables, and baseline FM, weight changes and TEI during 12-week regular 
exercise acting as the covariates. The mean values obtained from the ANCOVAs were 
used to interpret group differences. A p value of less than 0.05 was considered 
statistically significant. Data were analyzed with the Statistical Analysis System 195 
(version 9.01; SAS Institute Inc., Cary, NC, USA). 
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3. Results 
Attendance at exercise sessions was 87% (range, 54% to 100%) for MIF obesity 
group, and 85% (range 41% to 100%) for HIF obesity group. Table 1 contains baseline 
characteristics of study participants and their responses to regular aerobic exercise. 200 
There were no differences at baseline between groups for age, prevalence of basal 
disease, medication uses except for hypertension, alcohol and smoking habit, BMI 
and %fat, while height, weight, FM and FFM were significantly higher in HIF obesity 
than those values in MIF obesity. V
．
O2max was significantly lower in HIF obesity than 
that in MIF obesity. Significant reductions were observed in weight, BMI, FM 205 
and %fat within each group. Significant increases in V
．
O2max, not in AT and heart rate 
at AT, were detected within each group. ANOVA revealed no significant interactions (p 
= 0.20–0.95) for all variables between MIF and HIF obesity. 
The values for energy intake and expenditure during 2-week periods are shown in 
Table 2. There were no baseline differences for TEI and macronutrient balances 210 
between the two groups. For both groups, although TEI and macronutrient balance 
remained unchanged, TEE and PAEE significantly increased during the study period. 
However, no significant interactions (p = 0.19–0.92) were detected among the groups 
in the absolute change of any variable. 
Table 3 shows comparisons between the groups in baseline abdominal fat, other 215 
cardiovascular risk factors and its responses to regular aerobic exercise. Although 
there was no significant difference in SF area between the groups at baseline, 
participants with HIF obesity exhibited greater IF and TF areas than that in MIF 
obesity. Although regular aerobic exercise significantly reduced all abdominal fat 
variables in both groups, significantly greater reductions in IF and TF areas were 220 
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observed in participants with HIF obesity compared to those with MIF obesity. 
Baseline levels of FFA and LDL cholesterol were significantly higher in HIF group 
than MIF group. Total and LDL cholesterol, and triglycerides in both groups, and 
diastolic BP and HDL cholesterol in the MIF group were significantly improved after 
the regular exercise despite the fact that the interactions did not reach statistical 225 
significance in these cardiovascular risk factors. 
Figure 1 illustrates abdominal fat responses to regular aerobic exercise after 
adjusting for possible confounders (baseline FM, weight change and TEI during 
regular aerobic exercise), which represents the overall energy balance of the 12-week 
intervention. ANCOVAs demonstrated that reductions in IF and TF areas were 230 
significantly greater in HIF obesity compared to those in MIF obesity after controlling 
for covariates. 
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4. Discussion 
The present study was conducted to determine the effects of obesity phenotype on 
IF response to regular exercise. We hypothesized participants classified as HIF obesity 235 
would reduce IF, to a greater extent, than those classified as MIF obesity. It was found 
that when baseline FM, weight change and TEI were controlled for in the analyses, 
those with HIF obesity exhibited greater reductions in IF and TF areas than those with 
MIF obesity. 
These phenomena might be explained by enhanced lipolytic properties of IF 240 
tissues. It seems that IF tissue has higher lipolytic responses to catecholamine 
compared to SF tissue [31], which markedly increases during endurance exercise in an 
intensity-dependent manner [32]. On the other hand, IF tissue has lower antilipolytic 
responses to insulin compared to SF tissue [33], which gradually decreases during 
prolonged exercise. A previous report [16] indicated higher lipid concentrations in HIF 245 
obesity than MIF obesity in men. However, whole-body fat oxidation did not differ 
between HIF and MIF obesity phenotypes. In the present study, we also demonstrated 
that whole-body fat loss did not differ significantly between HIF and MIF obesity 
phenotypes. In this respect, our results were consistent with the previous study. This 
indicated that fat availability from IF tissue during exercise might be higher in HIF 250 
obesity than MIF obesity. 
Increased growth hormone (GH) concentrations during exercise could also be 
proposed as a potential mechanism. GH is a strong lipolytic hormone that significantly 
increases during endurance exercise [34]. In an in-vitro study using rat adipocytes [35], 
GH additions stimulated FFA release from both IF and SF adipocytes, and its effects 255 
were more prominent in IF adipocytes compared to SF adipocytes. In a recent human 
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study [36], GH administration induced greater reductions of IF tissue than SF tissue. 
Obesity is associated with a decrease in insulin-like growth factor-I and deficits in GH 
secretion. This is particularly apparent in individuals with accumulation of visceral 
adiposity [37]. Increases in FFA, a hallmark of visceral adiposity, are known to 260 
decrease GH secretion. Svensson et al. [38] tested the effectiveness of GH therapy in 
men with visceral obesity. They observed a striking reduction in IF tissue (-18%) along 
with an increase in lean muscle mass (+2%). The effect of GH administration on fat 
distribution was more prominent in GH-deficient adults than in healthy obese men; 
similarly, central obesity known to decrease GH secretion may be sensitive to 265 
GH-induced lipolysis by aerobic exercise. However, it is unknown whether GH 
responses to acute aerobic exercise differ between HIF or MIF obesity phenotypes. In 
addition, since we did not measure participant’s blood concentration of GH during 
exercise and at rest, we were unable to address this issue. 
Another possible mechanism is the influence of BMR on abdominal fat tissue. 270 
Some investigators have reported that IF tissue was positively related to BMR in 
middle-aged obese adults. Similar, yet inconsistent, results have been found for women 
[39]. Most studies in men using CT as well as anthropometric variables such as waist 
and waist to hip ratio showed comparable results, indicating that IF tissue is an 
important determinant of BMR [40]. With this in mind, we could speculate that 275 
increased BMR during exercise and at rest induced differences in total energy 
expenditure between HIF and MIF obesity phenotypes. The uniaxial accelerometer in 
our study estimated BMR using age, height, and weight as well as sex, but did not 
consider the altered fat oxidation rate associated with visceral adiposity. Therefore, the 
accelerometer might have underestimated TEE in HIF obesity. This inaccurate 280 
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measurement of BMR may have created greater IF reductions for the HIF obesity 
phenotype. It has been reported that fat oxidation rate during resting conditions was 
also related to obesity phenotype [36]. Because fat oxidation rate is related to plasma 
FFA concentrations, an enhanced release of the metabolite from IF adipose tissue may 
increase the fat oxidation rate in participants with HIF. Indeed, our HIF participants 285 
showed significantly higher resting FFA concentrations than MIF groups. Overall, 
these potential mechanisms may have interactively affected the differences in IF 
response to regular aerobic exercise between the two groups. 
Several intervention studies have examined the influences of obesity phenotypes 
on fat distributions in response to lifestyle modification such as diet alone or in 290 
combination with exercise. Leenen et al. [41] demonstrated that the amount of IF loss 
during weight loss was related to the initial amount of IF accumulation. This suggests 
that obese people with an initial abundance of IF preferentially lose IF compared to 
those people with less IF. Additionally, Okura et al. [11] showed that IF type (≥ 110 
cm2) obese women had significantly greater improvements in body fat distribution 295 
compared to SF type (< 110 cm2) obese women. Therefore, our observation that body 
fat distribution can be reduced to a great extent by regular exercise in those with high 
levels of IF is consistent with several previous studies. 
One strength of our study was our ability to determine that the negative energy 
balance in both phenotypes was caused by increased energy expenditure during the 300 
12-week exercise intervention. Energy intake in the present study was assessed by a 
3-day WDR which has often been used as the criterion method for exterminating 
energy intake. Moreover, there were no significant changes in energy intake during the 
intervention in both obesity phenotypes. Therefore, it is likely that beneficial effects 
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on abdominal fat tissues were mainly induced by increased physical activities alone. 305 
Previous studies solely determined the effects of obesity phenotypes on abdominal fat 
tissues in response to dietary modification with or without regular exercise [11, 17].  
Our study has some limitations. First, the exercise mode was not rigorously 
controlled (i.e., intensity and frequency). Exercise intensity has been reported to affect 
IF fat availability due to increased catecholamine [42]. With regard to variation of 310 
exercise frequency, it is known that the amount of physical activity (energy 
expenditure) is more important for reducing abdominal fat than the frequency of 
exercise [13]. However, there was no significant difference in weight change which 
would indicate differential energy balance accumulations over the intervention period. 
Moreover, our data were analyzed using ANCOVA with weight change as a covariate, 315 
and the influence of differential energy expenditure on IF tissue was excluded in the 
results of this study. Second, since we divided participants into two obesity phenotypes 
based on their initial levels of IF area, their responses to regular aerobic exercise might 
be partly affected by so-called “regression to the mean” effects. We are unlikely to be 
able to eliminate these effects, so the values of IF area reduction could be 320 
overestimated. It is possible that these limitations may have interfered with the effects 
of obesity phenotype on IF responses to the regular aerobic exercise. 
In summary, as the amount of SF lost in response to 2–3 kg of exercise-induced 
weight loss did not differ between MIF and HIF obesity phenotypes, the improvement 
in IF area was significantly greater for those with HIF obesity than for those with MIF 325 
obesity. These results suggest that IF responses to regular exercise predominantly 
depend on the obesity phenotype. In clinical settings for obesity treatments through 
exercise, clinical care personnel should consider that individuals with accumulated IF 
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area may exhibit a more sensitive IF response to regular exercise compared with MIF 
obesity, and therefore, they need to deliver appropriate exercise prescriptions for those 330 
with both MIF and HIF obesity phenotypes to improve IF accumulation and prevent 
CVD events. 
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Tables & Figure 
Table 1. Baseline physical characteristics and responses to regular aerobic exercise. 
    MIF obesity (n = 33) 
HIF obesity 
(n = 24) 
p for  
interaction 
Age, yrs  52.9 ± 10.6  53.5 ± 9.5   
Hypertension, n (%)  25 (75.8) 19 (79.2)  
Dyslipidemia, n (%)  23 (69.7) 21 (87.5)  
Diabetes mellitus, n (%)  4 (12.1) 4 (16.7)  
Antihypertensive medication use, n (%) 15 (45.5) 4 (16.7)*  
Lipid-lowering medication use, n (%) 4 (12.1) 2 (8.3)  
Hypoglycemic medication use, n (%) 3 (9.1) 1 (4.2)  
Never-drinker, n (%)  7 (21.2) 6 (25.0)  
Past-drinker, n (%)  1 (3.0) 0 (0)  
Current drinker, n (%)  25 (75.8) 18 (75.0)  
Never-smoker, n (%)  12 (36.4) 5 (20.8)  
Past-smoker, n (%)  18 (54.6) 14 (58.3)  
Current smoker, n (%)  3 (9.1) 5 (20.8)  
Height, cm  166.3 ± 5.7  170.9 ± 5.8*   
Weight, kg pre 80.9 ± 10.1  88.8 ± 11.3* 0.20  
 post 78.6 ± 10.2  85.6 ± 9.8  
  change -2.3 ± 2.2† -3.2 ± 3.0†   
BMI, kg/m2 pre 29.2 ± 3.1  30.3 ± 3.1 0.30  
 post 28.3 ± 3.0  29.2 ± 2.8  
  change -0.9 ± 0.7† -1.1 ± 1.0†   
Fat mass, kg pre 25.6 ± 6.5  29.7 ± 6.3* 0.31  
 post 23.2 ± 6.9  26.8 ± 5.7  
  change -2.4 ± 1.9† -3.0 ± 1.9†   
Fat-free mass, kg pre 55.3 ± 5.5  59.1 ± 6.9* 0.34  
 post 55.4 ± 5.5  58.8 ± 5.8  
  change 0.1 ± 1.2  -0.3 ± 1.7   
Percentage of fat mass, % pre 31.3 ± 4.5  33.3 ± 3.9 0.95  
 post 29.1 ± 5.4  31.1 ± 3.9  
  change -2.3 ± 1.9† -2.2 ± 1.5†   
V
．
O2max‡, ml/kg/min pre 30.4 ± 5.0  27.7 ± 3.7* 0.61 
 post 33.3 ± 6.2  31.1 ± 5.5  
 change 2.9 ± 3.8†  3.4 ± 3.9†  
Anaerobic threshold‡,  pre 18.1 ± 3.7  16.5 ± 2.6  0.37  
ml/kg/min post 19.4 ± 4.6  18.5 ± 3.0   
  change 1.4 ± 2.2  1.9 ± 2.6   
Heart rate at anaerobic  pre 116.8 ± 17.0  111.3 ± 16.0  0.67  
threshold§, bpm post 114.5 ± 16.1  110.5 ± 13.9   
 change -2.3 ± 13.0  -0.8 ± 11.8   
Values are mean ± standard deviation, MIF: moderate intra-abdominal fat, HIF: high intra-abdominal fat, 
BMI: body mass index, V
．
O2max: maximal oxygen uptake, *significant differences between groups at pre 
by unpaired t test or chi-squared test. †significant changes within group by paired t test. Hypertension 
was defined as systolic blood pressure ≥ 140 mmHg, and/or diastolic blood pressure ≥ 90 mmHg, and/or 
receiving antihypertensive medication. Dyslipidemia was defined as the presence of any one of the 
following four risks: 1) total cholesterol ≥ 220 mg/dl, 2) low-density lipoprotein cholesterol ≥ 140 mg/dl, 
3) high-density lipoprotein cholesterol < 40 mg/dl, 4) triglycerides ≥ 150 mg/dl, and/or receiving 
lipid-lowering medication. Fasting blood glucose ≥ 126 mg/dl and/or receiving hypoglycemic medication 
was the criterion for diabetes mellitus. ‡32 data in SF obesity and 23 in IF obesity were available. §31 
data in SF obesity and 23 in IF obesity were available. 
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Table 2. Changes in energy intake and expenditure during the 12-week exercise intervention. 
    
MIF obesity 
(n = 33) 
HIF obesity 
(n = 24) 
p for  
interaction
Total energy intake, kcal/d pre 2157 ± 408 2366 ± 567 0.92 
 wk 9–10 2152 ± 451 2350 ± 482  
  change -5 ± 462 -16 ± 400  
  Carbohydrate intake, % pre 52.5 ± 8.1 50.5 ± 9.0  0.83 
 wk 9–10 53.7 ± 8.8 51.2 ± 9.4   
 change 1.2 ± 9.1 0.7 ± 7.8   
  Protein intake, % pre 14.8 ± 2.9 16.3 ± 3.1  0.19 
 wk 9–10 15.5 ± 2.4 16.1 ± 3.0   
 change 0.7 ± 2.5 -0.2 ± 2.6   
  Fat intake, % pre 24.6 ± 5.8 24.5 ± 4.0  0.83 
 wk 9–10 24.7 ± 5.9 24.8 ± 5.1   
 change 0.1 ± 8.2 0.2 ± 5.8   
Total energy expenditure, kcal/d pre 2295 ± 259 2380 ± 269 0.85 
 wk 9–10 2485 ± 262 2562 ± 326  
  change 189 ± 148† 182 ± 156†  
Physical activity  pre 290 ± 123 259 ± 115 0.83 
energy expenditure, kcal/d wk 9–10 461 ± 150 438 ± 135  
  change 171 ± 131† 179 ± 121†  
Values are mean ± standard deviation, MIF: moderate intra-abdominal fat, HIF: high 
intra-abdominal fat, *significant difference between groups at pre by unpaired t test. †significant 
changes within group by paired t test. 
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Table 3. Abdominal fat and other cardiovascular risk factors at baseline and responses to regular 
aerobic exercise. 
    MIF obesity (n = 33) 
HIF obesity 
(n = 24) 
p for  
interaction 
Intra-abdominal fat area, cm2 pre 149.7 ± 35.4  242.4 ± 34.4* < 0.01 
 post 134.6 ± 43.1  199.1 ± 39.7  
 change -15.1 ± 26.0† -43.3 ± 41.9†   
Subcutaneous fat area, cm2 pre 211.6 ± 85.7  235.0 ± 80.3 0.04  
 post 195.1 ± 88.1  203.0 ± 68.5  
 change -16.5 ± 23.3† -32.1 ± 32.9†   
Total fat area, cm2 pre 361.3 ± 102.9 477.4 ± 98.8* < 0.01 
 post 329.7 ± 107.4 402.1 ± 74.8  
 change -31.6 ± 43.3† -75.4 ± 67.7†   
Systolic BP, mmHg pre 140.1 ± 14.9  143.2 ± 18.0  0.58 
 post 137.4 ± 13.9  138.9 ± 15.2   
  change -2.7 ± 10.3  -4.3 ± 10.6   
Diastolic BP, mmHg pre 92.1 ± 10.2  93.9 ± 13.1  0.40 
 post 89.5 ± 10.4  92.9 ± 12.1   
  change -2.6 ± 7.1†  -1.0 ± 7.1   
Free fatty acid, mEq/l pre 0.59 ± 0.21  0.73 ± 0.24*  0.30 
 post 0.56 ± 0.19  0.63 ± 0.25   
  change -0.03 ± 0.24  -0.10 ± 0.22†   
Total cholesterol, mg/dl pre 218.0 ± 32.4  232.4 ± 30.2  0.38 
 post 203.3 ± 28.2  212.0 ± 33.4   
  change -14.7 ± 20.1† -20.4 ± 26.7†   
LDL cholesterol, mg/dl pre 130.1 ± 30.9  147.5 ± 30.4*  0.39 
 post 120.7 ± 23.3  133.5 ± 31.7   
  change -9.5 ± 15.0† -13.9 ± 22.3†   
HDL cholesterol, mg/dl pre 57.0 ± 16.2  50.6 ± 9.2  0.83 
 post 59.0 ± 18.5  52.3 ± 9.3   
  change 2.0 ± 5.1†  1.7 ± 6.1   
Triglycerides, mg/dl pre 164.1 ± 100.8 172.0 ± 74.3  0.80 
 post 118.3 ± 60.9  131.1 ± 48.0   
  change -45.7 ± 73.0† -40.8 ± 61.2†    
Fasting blood glucose, mg/dl pre 98.7 ± 13.9  103.0 ± 17.1  0.33  
 post 103.2 ± 27.1  103.2 ± 13.3   
  change 4.5 ± 16.5  0.2 ± 15.1    
Values are mean ± standard deviation, MIF: moderate intra-abdominal fat, HIF: high 
intra-abdominal fat, BP: blood pressure, LDL: low-density lipoprotein, HDL: high-density 
lipoprotein, *significant difference between groups at pre by unpaired t test. †significant changes 
within group by paired t test. Thirty and 23 data from blood samples were available in MIF and 
HIF groups, respectively. 
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Figure 1. Abdominal fat responses to regular aerobic exercise after adjusting for baseline fat 
mass, weight changes and total energy intake during regular aerobic exercise. Values are 
expressed as mean (standard error). IF: intra-abdominal fat, SF: subcutaneous fat, TF: total fat 
(IF plus SF areas), MIF: moderate intra-abdominal fat, HIF: high intra-abdominal fat. 
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